blaVIM mediated carbapenem resistance in Pseudomonas aeruginosa
Carbapenem-Resistant Pseudomonas aeruginosa (CRPA) is becoming a growing problem in tertiary healthcare facilities with the acquisition of metallo-beta-lactamase (MBL) genes, specifically the Verona Integron-encoded Metallo-beta-lactamase (VIM) gene, making standard 37 -lactam-based treatment of this pathogen ineffecti...